Literature DB >> 28149610

Antifungal use in intensive care units: another uncertainty that highlights the need for precision medicine.

Rima Moghnieh1, Zeina A Kanafani2, Souha S Kanj2.   

Abstract

Year:  2016        PMID： 28149610      PMCID： PMC5227267          DOI： 10.21037/jtd.2016.12.97

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

Authors:  M Puig-Asensio; B Padilla; J Garnacho-Montero; O Zaragoza; J M Aguado; R Zaragoza; M Montejo; P Muñoz; I Ruiz-Camps; M Cuenca-Estrella; B Almirante
Journal:  Clin Microbiol Infect       Date:  2013-10-11       Impact factor: 8.067

2.  Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.

Authors:  David Ferreira; Frederic Grenouillet; Gilles Blasco; Emmanuel Samain; Thierry Hénon; Alain Dussaucy; Laurence Millon; Mariette Mercier; Sebastien Pili-Floury
Journal:  Intensive Care Med       Date:  2015-04-18       Impact factor: 17.440

3.  Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

Authors:  Elie Azoulay; Hervé Dupont; Alexis Tabah; Olivier Lortholary; Jean-Paul Stahl; Adrien Francais; Claude Martin; Bertand Guidet; Jean-François Timsit
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

4.  Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.

Authors:  Daniel H Kett; Elie Azoulay; Pablo M Echeverria; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2011-04       Impact factor: 7.598

5.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Authors:  Luis Ostrosky-Zeichner; Shmuel Shoham; Jose Vazquez; Annette Reboli; Robert Betts; Michelle A Barron; Mindy Schuster; Marc A Judson; Sanjay G Revankar; Juan Pablo Caeiro; Julie E Mangino; David Mushatt; Roger Bedimo; Alison Freifeld; Minh Hong Nguyen; Carol A Kauffman; William E Dismukes; Andrew O Westfall; Jeanna Beth Deerman; Craig Wood; Jack D Sobel; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2014-02-18       Impact factor: 9.079

7.  Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

Authors:  Mindy G Schuster; John E Edwards; Jack D Sobel; Rabih O Darouiche; Adolf W Karchmer; Susan Hadley; Gus Slotman; Helene Panzer; Pinaki Biswas; John H Rex
Journal:  Ann Intern Med       Date:  2008-07-15       Impact factor: 25.391

8.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Authors:  Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

9.  Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.

Authors:  Brunella Posteraro; Gennaro De Pascale; Mario Tumbarello; Riccardo Torelli; Mariano Alberto Pennisi; Giuseppe Bello; Riccardo Maviglia; Giovanni Fadda; Maurizio Sanguinetti; Massimo Antonelli
Journal:  Crit Care       Date:  2011-10-22       Impact factor: 9.097

10.  Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010).

Authors:  Olivier Lortholary; Charlotte Renaudat; Karine Sitbon; Yoann Madec; Lise Denoeud-Ndam; Michel Wolff; Arnaud Fontanet; Stéphane Bretagne; Françoise Dromer
Journal:  Intensive Care Med       Date:  2014-08-06       Impact factor: 17.440
View more
  1 in total

1.  Lessons from uncertainty on antifungal treatment in ICU.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Antonino Giarratano
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.